Selected article for: "cell state and human cell"

Author: Bannerman, Bridget P; Júlvez, Jorge; Oarga, Alexandru; Blundell, Tom L; Moreno, Pablo; Floto, R Andres
Title: Integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19
  • Cord-id: b5gkhs07
  • Document date: 2021_8_5
  • ID: b5gkhs07
    Snippet: The coronavirus disease 2019 (COVID-19) pandemic caused by the new coronavirus (SARS-CoV-2) is currently responsible for more than 3 million deaths in 219 countries across the world and with more than 140 million cases. The absence of FDA-approved drugs against SARS-CoV-2 has highlighted an urgent need to design new drugs. We developed an integrated model of the human cell and SARS-CoV-2 to provide insight into the virus’ pathogenic mechanism and support current therapeutic strategies. We show
    Document: The coronavirus disease 2019 (COVID-19) pandemic caused by the new coronavirus (SARS-CoV-2) is currently responsible for more than 3 million deaths in 219 countries across the world and with more than 140 million cases. The absence of FDA-approved drugs against SARS-CoV-2 has highlighted an urgent need to design new drugs. We developed an integrated model of the human cell and SARS-CoV-2 to provide insight into the virus’ pathogenic mechanism and support current therapeutic strategies. We show the biochemical reactions required for the growth and general maintenance of the human cell, first, in its healthy state. We then demonstrate how the entry of SARS-CoV-2 into the human cell causes biochemical and structural changes, leading to a change of cell functions or cell death. A new computational method that predicts 20 unique reactions as drug targets from our models and provides a platform for future studies on viral entry inhibition, immune regulation, and drug optimisation strategies. The model is available in BioModels (https://www.ebi.ac.uk/biomodels/MODEL2007210001) and the software tool, findCPcli, that implements the computational method is available at https://github.com/findCP/findCPcli.

    Search related documents:
    Co phrase search for related documents
    • acid degradation and long chain: 1
    • action viral mechanism and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • acute respiratory syndrome coronavirus and additional reaction: 1
    • acute respiratory syndrome coronavirus and additional resource: 1, 2, 3
    • acute respiratory syndrome coronavirus and long chain: 1, 2, 3, 4, 5
    • acute respiratory syndrome coronavirus and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and low quality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and low quality score: 1
    • acute respiratory syndrome coronavirus and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and macrophage cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory syndrome coronavirus and macrophage cell specific: 1
    • acute respiratory syndrome coronavirus and macrophage epithelial: 1, 2, 3
    • acute respiratory syndrome coronavirus and macrophage epithelial cell: 1
    • acyl coa synthetase and long chain: 1, 2, 3
    • long chain and lung inflammation: 1
    • long chain and macrophage cell: 1
    • lopinavir ritonavir and low quality: 1, 2, 3, 4, 5
    • lopinavir ritonavir and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8
    • low quality and lung inflammation: 1, 2